Skip to main content
Premium Trial:

Request an Annual Quote

Reimbursement Won't Help If They're Not Covered

The name of the game for pharmacogenomics is reimbursement: your diagnostic or therapeutic won't mean much if no one can pay for it. So it's a matter of concern for everyone that in the US alone, 45 million people have no health insurance. This interactive graphic from the Wall Street Journal provides information about how several states have new plans to tackle the problem.


The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.